Sequential use of sorafenib and sunitinib in advanced renal-cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases-Reference-Cited by-同舟云学术

Sequential use of sorafenib and sunitinib in advanced renal-cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases

Published:2011-05-23 Issue:8b Volume:108 Page:E250-E257
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Porta Camillo,Procopio Giuseppe,Cartenì Giacomo,Sabbatini Roberto,Bearz Alessandra,Chiappino Isabella,Ruggeri Enzo Maria,Re Giovanni Lo,Ricotta Riccardo,Zustovich Fable,Landi Lorenza,Calcagno Anna,Imarisio Ilaria,Verzoni Elena,Rizzo Mimma,Paglino Chiara,Guadalupi Valentina,Bajetta Emilio

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2011.10186.x/fullpdf

Reference31 articles.

1. Sorafenib for treatment of renal cell carcinoma: final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial;Escudier;J Clin Oncol,2009

2. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial;Escudier;Lancet,2007

3. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma;Hudes;N Engl J Med,2007

4. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma;Motzer;J Clin Oncol,2009

5. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial;Motzer;Lancet,2008

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Venetoclax Synergizes Sunitinib in Renal Cell Carcincoma through Inhibition of Bcl-2;Anti-Cancer Agents in Medicinal Chemistry;2023-11

2. Mechanisms of sunitinib resistance in renal cell carcinoma and associated opportunities for therapeutics;British Journal of Pharmacology;2023-10-19

3. Cardiovascular profile of contemporary treatments of renal cell carcinoma: A single-center prospective study;International Journal of Cardiology;2023-06

4. Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers;Drug Resistance Updates;2023-03

5. Optimal sequential therapy using tyrosine kinase inhibitors as the 1st-line treatment in patients with metastatic renal cell carcinoma: A nationwide multicenter study;Asian Journal of Urology;2023-03